Patents
US 12070492 B2: Therapeutic compositions and methods with cytokine signaling immunomodulators
- Granted
- 2024-08-27
- Filed
- 2017-05-10 application 16099093
- Type
- Utility · 6 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
A method generally includes co-administering to a subject a composition that includes an antigen and a cytokine signaling immunomodulator. The method can be for treating a subject for abuse of a drug, treating a subject for toxicity from drug abuse, treating a subject for infection by a pathogen, treating a subject for a non-communicable disease, or for increasing antibody production against the antigen. The antigen can be component of a vaccine. The cytokine-signaling immunomodulator is effective to improve the subject's immune response to the antigen compared to the subject's immune response to the antigen without the cytokine-signaling immunomodulator.
Source: PVGPATDIS, file of 2026-04-10 (ipg240827.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| Hennepin Healthcare Research Institute 3 patents | US company or organization | Minneapolis, MN | HENNEPIN HEALTHCARE RESEARCH INSTITUTE Nonprofit EXACT high confidence: identical full name and state | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Marco Pravetoni | Minneapolis, MN | 2 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K39/0018 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P25/30 | PVGPATDIS, file of 2026-04-10 |
| C07K | Peptides | C07K16/247 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2019-01-31 | Name change Change of name | MINNEAPOLIS MEDICAL RESEARCH FOUNDATION signed 2018-08-01 | HENNEPIN HEALTHCARE RESEARCH INSTITUTE MINNEAPOLIS, MN | 49524/521 | ECORSEXC, file of 2026-09-25 |
| 2019-01-31 | Assignment Assignment of assignor's interest | PRAVETONI, MARCO signed 2017-06-15 | MINNEAPOLIS MEDICAL RESEARCH FOUNDATION MINNEAPOLIS, MN | 48212/328 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.